BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma-derived cell line DEV

Human Pathology

Volumn 37, Issue 6, 2006, Pages 675-683

  Atayar, Çiǧdem ^a   Kok, Klaas ^a   Kluiver, Joost ^a   Bosga, Anneke ^a   van den Berg, Eva ^a   van der Vlies, Pieter ^a   Blokzijl, Tjasso ^a   Harms, Geert ^a   Davelaar, Inge ^a   Sikkema Raddatz, Birgit ^a   Martin Subero, Jose Ignacio ^b   Siebert, Reiner ^b   Poppema, Sibrand ^a   van den Berg, Anke ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

17q24 deletion; BCL6 ABR breakpoint; DEV; Hodgkin's lymphoma; NLPHL

Indexed keywords

B7 ANTIGEN; CD20 ANTIBODY; CD22 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; CD86 ANTIGEN; DNA; IMMUNOGLOBULIN A2; PROTEIN BCL 6; BCL6 PROTEIN, HUMAN; DNA BINDING PROTEIN; MICROSATELLITE DNA;

ADULT; ARTICLE; CHROMOSOME 14; CHROMOSOME 22; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CYTOGENETICS; DNA FLANKING REGION; DNA ISOLATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENETIC ANALYSIS; HISTIOCYTE; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LEYDIG CELL; LYMPHOCYTE; MALE; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; CHROMOSOME 17; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME MAP; GENETIC MARKER; GENETICS; HODGKIN DISEASE; HOMOZYGOTE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; CYTOGENETIC ANALYSIS; DNA-BINDING PROTEINS; GENETIC MARKERS; HODGKIN DISEASE; HOMOZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; MALE; MICROSATELLITE REPEATS; MIDDLE AGED;

EID: 33745713593     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.01.018     Document Type: Article

References (38)

1. Maggio E.M., Stekelenburg E., Van Den Berg A., and Poppema S. TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus. Int J Cancer 94 (2001) 60-66
2. Maggio E.M., Van Den Berg A., de Jong D., Diepstra A., and Poppema S. Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin's lymphoma. Am J Pathol 162 (2003) 29-35
3. Kuppers R., Rajewsky K., Zhao M., et al. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A 91 (1994) 10962-10966
4. Chui D.T., Hammond D., Baird M., Shield L., Jackson R., and Jarrett R.F. Classical Hodgkin lymphoma is associated with frequent gains of 17q. Genes Chromosomes Cancer 38 (2003) 126-136
5. Van Den Berg A., Visser L., and Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells-a possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma. Am J Pathol 154 (1999) 1685-1691
6. Schwering I., Brauninger A., Klein U., et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 101 (2003) 1505-1512
7. Drexler H.G., and Minowada J. Hodgkin's disease derived cell lines: a review. Hum Cell 5 (1992) 42-53
8. Poppema S., De Jong B., Atmosoerodjo J., Idenburg V., Visser L., and De Ley L. Morphologic, immunologic, enzymehistochemical and chromosomal analysis of a cell line derived from Hodgkin's disease. Evidence for a B-cell origin of Sternberg-Reed cells. Cancer 55 (1985) 683-690
9. Poppema S., Visser L., De Jong B., Brinker M., Atmosoerodjo J., and Timens W. The typical Reed-Sternberg phenotype and Ig gene rearrangement of Hodgkin's disease derived cell line ZO indicating a B-cell origin. Recent Results Cancer Res 117 (1989) 67-74
10. Berglund M., Flordal E., Gullander J., et al. Molecular cytogenetic characterization of four commonly used cell lines derived from Hodgkin lymphoma. Cancer Genet Cytogenet 141 (2003) 43-48
11. Drexler H.G., Dirks W.G., Matsuo Y., and MacLeod R.A. False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia 17 (2003) 416-426
12. Mitelman F, editor. 1995: An international system for human cytogenetic nomenclature. Basel: S. Karger; 1995.
13. Fiegler H., Carr P., Douglas E.J., et al. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 36 (2003) 361-374
14. Kok K., Dijkhuizen T., Swart Y.E., et al. Application of a comprehensive subtelomere array in clinical diagnosis of mental retardation. Eur J Med Genet 48 (2005) 250-262
15. Butler M.P., Iida S., Capello D., et al. Alternative translocation breakpoint cluster region 5′ to BCL-6 in B-cell non-Hodgkin's lymphoma. Cancer Res 62 (2002) 4089-4094
16. Taylor C.R., and Riley C.R. Molecular morphology of Hodgkin lymphoma. Appl Immunohistochem Mol Morphol 9 (2001) 187-202
17. Atayar C., and Poppema S. Nodular lymphocyte predominance type of Hodgkin's lymphoma. In: Jaffe E.S. (Ed). Diagnostic hematopathology (2006), Harcourt Health Sciences, Oxford [in press]
18. Anagnostopoulos I., Hansmann M.L., Franssila K., et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96 (2000) 1889-1899
19. Nicholas D.S., Harris S., and Wright D.H. Lymphocyte predominance Hodgkin's disease-an immunohistochemical study. Histopathology 16 (1990) 157-165
20. Rudiger T., Ott G., Ott M.M., Muller-Deubert S.M., and Muller-Hermelink H.K. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry. Am J Surg Pathol 22 (1998) 1184-1191
21. Ranjan P., and Naresh K.N. CD30 expression in L&H cells of Hodgkin's disease, nodular lymphocyte predominant type. Histopathology 42 (2003) 406-407
22. Carbone A., Gloghini A., Gaidano G., Dalla-Favera R., and Falini B. BCL-6 protein expression in human peripheral T-cell neoplasms is restricted to CD30+ anaplastic large-cell lymphomas. Blood 90 (1997) 2445-2450
23. Chiarle R., Podda A., Prolla G., Gong J., Thorbecke G.J., and Inghirami G. CD30 in normal and neoplastic cells. Clin Immunol 90 (1999) 157-164
24. Steimle-Grauer S.A., Tinguely M., Seada L., Fellbaum C., and Hansmann M.L. Expression patterns of transcription factors in progressively transformed germinal centers and Hodgkin lymphoma. Virchows Arch 442 (2003) 284-293
25. Van Den Berg A., Kroesen B.J., Kooistra K., et al. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 37 (2003) 20-28
26. Falini B., Bigerna B., Pasqualucci L., et al. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. Blood 87 (1996) 465-471
27. Wlodarska I., Nooyen P., Maes B., et al. Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. Blood 101 (2003) 706-710
28. Renne C., Martin-Subero J.I., Hansmann M.L., and Siebert R. Molecular cytogenetic analyses of immunoglobulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition. J Mol Diagn 7 (2005) 352-356
29. Franke S., Wlodarska I., Maes B., et al. Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances. Blood 97 (2001) 1845-1853
30. Falzetti D., Crescenzi B., Matteuci C., et al. Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease. Haematologica 84 (1999) 298-305
31. Kikuchi A. Modulation of Wnt signaling by Axin and Axil. Cytokine Growth Factor Rev 10 (1999) 255-265
32. Liu W., Dong X., Mai M., et al. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet 26 (2000) 146-147
33. Nagai H., Yabe A., Mine N., et al. Down-regulation in human cancers of DRHC, a novel helicase-like gene from 17q25.1 that inhibits cell growth. Cancer Lett 193 (2003) 41-47
34. Dermott J.M., and Dhanasekaran N. Determining cellular role of G alpha 12. Methods Enzymol 344 (2002) 298-309
35. Dhanasekaran N., and Dermott J.M. Signaling by the G12 class of G proteins. Cell Signal 8 (1996) 235-245
36. Jiang H., Wu D., and Simon M.I. The transforming activity of activated G alpha 12. FEBS Lett 330 (1993) 319-322
37. von Lindern M., Parren-van Amelsvoort M., van Dijk T., et al. Protein kinase C alpha controls erythropoietin receptor signaling. J Biol Chem 275 (2000) 34719-34727
38. Besson A., and Yong V.W. Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression. Mol Cell Biol 20 (2000) 4580-4590